Regional Monitoring EECA
by ECUO PLWH
Showing 1-443 of 443 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.544172.5443190Not specifiedNot specifiedNot specified
2Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab1.09328209206065.5913682897402.382015Not specifiedNot specifiedNot specified
3UkraineGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.26828132406016.0913554218083.862016Not specifiedNot specifiedNot specified
4Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml16.14228116.142283679.92IDA Foundation2015Not specifiedYesNot specified
5Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.540172.5402900Not specifiedNot specifiedNot specified
6Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml66.29-166.29--Not specifiedNot specifiedNot specified
7Republic of KazakhstanGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab0.0442343600602.6439060103118.42015Not specifiedNot specifiedNot specified
8UkraineGlobal FundGlaxoSmithKlineAbacavir (ABC)300mg tab0.425606025.5125.52015Not specifiedNot specifiedNot specified
9Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml6.75216.75213.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
10GeorgiaGlobal FundHetero labs Ltd.Abacavir (ABC)20mg/ml oral solution 240ml7.521617.52161620partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
11Kyrgyz RepublicGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.2125211806012.753534500.75UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
12Russian FederationGovernmentDrugs technologyAbacavir-ABCAbacavir (ABC)300mg tab1.15965521206069.5410920275939072015Not specifiedNot specifiedNot specified
13Republic of BelarusGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.18482991006011.09498555283.65UNICEF Supply Division20152015-05-24Not specifiedNot specifiedNot specified
14Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml12-112--Not specifiedNot specifiedNot specified
15Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.2333606014114Not specifiedNot specifiedNot specified
16Republic of BelarusGovernmentHetero Labs + ФарматехAbacavir (ABC)300mg tab0.33429008406020.0515014301030.69Фарматех ЗАО2015Not specifiedNot specifiedNot specified
17Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)600mg tab2.509760223203075.29200744151140162015Not specifiedNot specifiedNot specified
18GeorgiaGlobal FundMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.1832129606010.992162373.84partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
19Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)150mg tab0.6933180606041.630112521.62015Not specifiedNot specifiedNot specified
20Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253900060228.75650148687.5Not specifiedNot specifiedNot specified
21Republic of ArmeniaGlobal FundCipla LtdAbacavir (ABC)300mg tab0.19569006011.71151345.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
22Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.8125300060228.755011437.5Not specifiedNot specifiedNot specified
23UkraineGovernmentViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml0.08119101510.08119101595281.22016Not specifiedNot specifiedNot specified
24Republic of KazakhstanGovernmentKievmedpreparat, UkraineAbacavir (ABC)20mg/ml oral solution 240ml119.485961119.4859671210.082015Not specifiedNot specifiedNot specified
25Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253000060228.75500114375Not specifiedNot specifiedNot specified
26Republic of TajikistanGlobal FundViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml8-18--Not specifiedNot specifiedNot specified
27Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.47026060208.211208.21Not specifiedNot specifiedNot specified
28Republic of KazakhstanGovernmentMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.04311091600602.58184860476938.812015Not specifiedNot specifiedNot specified
29Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml45.621875145.6218759975002015Not specifiedNot specifiedNot specified
30Republiс of AzerbaijanGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.6048285606036.2947617274.04YesYesNot specified
31Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml37.44533137.4453319955.52YesYesNot specified
32Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)300mg tab1.1333264384060684406429963522015Not specifiedNot specifiedNot specified
33Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.5100172.51007250Not specifiedNot specifiedNot specified
34Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.1848606011.09111.09Not specifiedNot specifiedNot specified
35Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.43331590301353689VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
36Republic of KazakhstanGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.377730474003011.331015801150901.382015Not specifiedNot specifiedNot specified
37Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab4.002436197030120.06145399174566042015Not specifiedNot specifiedNot specified
38Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.5093443403015.28147822583.84IDA Foundation2015Not specifiedYesNot specified
39UkraineGovernmentCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.097264440605.8310746261.422016Not specifiedNot specifiedNot specified
40Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC60mg+30mg tab0.08336060515Not specifiedNot specifiedNot specified
41UkraineGovernmentGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab0.97971719303029.395731168434.092016Not specifiedNot specifiedNot specified
42Republiс of AzerbaijanGovernmentViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab1.7167219603051.573237698YesYesNot specified
43Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.16671950003042565002762500Not specifiedNot specifiedNot specified
44Republic of PolandGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.16671800030425600255000Not specifiedNot specifiedNot specified
45Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166766000304252200935000Not specifiedNot specifiedNot specified
46Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.5167-3015.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
47Republic of LatviaGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.6193030348.571348.57Not specifiedNot specifiedNot specified
48Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab0.5167303015.5115.5Not specifiedNot specifiedNot specified
49UkraineGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.02303030.6130.62015Not specifiedNot specifiedNot specified
50Kyrgyz RepublicGlobal FundCipla LtdAbamune-L BabyAbacavir+Lamivudine - FDC60mg+30mg tab0.0833282060547235UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
51Republic of LithuaniaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.13733030334.121334.12Viiv Healthcare UK LimitedNot specifiedYesNot specified
52Republic of PolandGovernmentViiV HealthcareTrizivirAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab9.791790060587.5158812.5Not specifiedNot specifiedNot specified
53Republic of KazakhstanGovernmentViiV HealthcareAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.10783877200606.4764620418091.412015Not specifiedNot specifiedNot specified
54Republic of KazakhstanGovernmentViiV HealthcareAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.10783600606.4760388.22015Not specifiedNot specifiedNot specified
55Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.5667432030171442448IDA Foundation20152015-12-222016-04-14NoNoNot specified
56Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps7.51380060450230103500Not specifiedNot specifiedNot specified
57Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.4167300030462.510046250Not specifiedNot specifiedNot specified
58Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.7975553782060107.859229799542312015Not specifiedNot specifiedNot specified
59Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.41672700030462.5900416250Not specifiedNot specifiedNot specified
60Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps13.09573030392.871392.87Not specifiedNot specifiedNot specified
61Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.833326403025882200IDA Foundation2015Not specifiedYesNot specified
62GeorgiaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.6486003018162029160partnership for supply. chain management (PFSCM)2015NoYesNot specified
63Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.416716200030462.554002497500Not specifiedNot specifiedNot specified
64Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.37471000794060142.48166799237655222015Not specifiedNot specifiedNot specified
65Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps3.60311103030108.093701400041.092015Not specifiedNot specifiedNot specified
66Republic of PolandGovernmentBristol-Myers SquibbEvotazAtazanavir+Cobicistat300mg+150mg tab16.253600030487.51200585000Not specifiedNot specifiedNot specified
67Republiс of AzerbaijanGovernmentCipla LtdAtazanavir+Ritonavir - FDC300mg+100mg tab2.236750403067.116811272.8YesYesNot specified
68Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)400mg tab5.043318060302.585316036.742015Not specifiedNot specifiedNot specified
69Republic of LatviaGovernmentJanssenPrezistaDarunavir (TCM)400mg tab7.81176060468.71468.7Not specifiedNot specifiedNot specified
70Republic of MoldovaGlobal FundJanssenDarunavir (TCM)600mg tab12.5405942060752.43157118131.51IDA Foundation2015Not specifiedYesNot specified
71Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab13.7881365030413.64455188206.2Not specifiedNot specifiedNot specified
72Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab13.7887650030413.6425501054782Not specifiedNot specifiedNot specified
73Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)800mg tab10.27191091030308.163697196250462015Not specifiedNot specifiedNot specified
74UkraineGovernmentJanssenDarunavir (TCM)400mg tab5.722206034237126542016Not specifiedNot specifiedNot specified
75Republic of ArmeniaGlobal FundJanssenDarunavir (TCM)600mg tab11.61806069632088VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
76Russian FederationGovernmentHetero labs Ltd.DarunavirDarunavir (TCM)600mg tab6.55033054060393.02509200047.192015Not specifiedNot specifiedNot specified
77Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab14.98546500030449.55155006968025Not specifiedNot specifiedNot specified
78Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)400mg tab4.604278438060276.25130733611416.252015Not specifiedNot specifiedNot specified
79Republic of LatviaGovernmentJanssenPrezistaDarunavir (TCM)600mg tab10.35536060621.321621.32Not specifiedNot specifiedNot specified
80Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)150mg tab2.75631920240661.585292Not specifiedNot specifiedNot specified
81Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)800mg tab8.63771587030259.13529137079.772015Not specifiedNot specifiedNot specified
82Republiс of AzerbaijanGovernmentJanssenPrezistaDarunavir (TCM)600mg tab20.566211520601233.97192236922.23YesYesNot specified
83Republic of BelarusGovernmentHetero Labs + ФарматехDarunavir (TCM)600mg tab6.98133168060418.88528221168.64Фарматех ЗАО2015Not specifiedNot specifiedNot specified
84Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)600mg tab6.8323215754060409.9435959147410322015Not specifiedNot specifiedNot specified
85UkraineGovernmentJanssenDarunavir (TCM)600mg tab8.5543140605137193688472016Not specifiedNot specifiedNot specified
86Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)600mg tab7.059544448060423.5774083137806.52015Not specifiedNot specifiedNot specified
87Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)600mg tab11.0258700060661.51450959175Not specifiedNot specifiedNot specified
88GeorgiaGlobal FundJanssenDarunavir (TCM)600mg tab11.61368060696228158688partnership for supply. chain management (PFSCM)2015NoYesNot specified
89Republic of LithuaniaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab17.29873030518.961518.96Not specifiedNot specifiedNot specified
90Republic of PolandGovernmentBristol-Myers SquibbRezolstaDarunavir+Cobicistat800mg+150mg tab14.166300030424.9810042498Not specifiedNot specifiedNot specified
91Republic of PolandGovernmentBristol-Myers SquibbRezolstaDarunavir+Cobicistat800mg+150mg tab14.1666600030424.982200934956Not specifiedNot specifiedNot specified
92Republic of LatviaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab15.62373030468.711468.71Not specifiedNot specifiedNot specified
93Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedDidanosine100mg tab0.02452826000601.4747100692372015Not specifiedNot specifiedNot specified
94Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine125mg caps0.9523379203028.57126436112.482015Not specifiedNot specifiedNot specified
95Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.733318903022631386VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
96Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps0.9503174903028.5158316621.33YesYesNot specified
97GeorgiaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.666718003020601200partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
98Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine400mg caps1.40113008303042.03433611822462.882015Not specifiedNot specifiedNot specified
99Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps5.61473030168.441168.44Not specifiedNot specifiedNot specified
100Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine250mg caps1.12874755003033.86158505366812015Not specifiedNot specifiedNot specified
101Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine2g powder1743721174372743242015Not specifiedNot specifiedNot specified
102Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine250mg caps0.4480301216192VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
103Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.39217098503041.76569952380111.252015Not specifiedNot specifiedNot specified
104Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps1.1285157603033.8417192581777.252015Not specifiedNot specifiedNot specified
105Republic of LatviaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab20.72633030621.791621.79Not specifiedNot specifiedNot specified
106Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-05-28Not specifiedNot specifiedNot specified
107Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.531800305251060556500Not specifiedNot specifiedNot specified
108Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.51500030525500262500Not specifiedNot specifiedNot specified
109Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-04-19Not specifiedNot specifiedNot specified
110Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.557000305251900997500Not specifiedNot specifiedNot specified
111UkraineGovernmentViiV HealthcareDolutegravir (as sodium salt)50mg tab6.83572478030205.07826169387.812016Not specifiedNot specifiedNot specified
112Republic of LithuaniaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab24.6693030740.071740.07Not specifiedNot specifiedNot specified
113Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab0.017760000300.5320001060Not specifiedNot specifiedNot specified
114Republic of LatviaGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab32.4843030974.521974.52Not specifiedNot specifiedNot specified
115Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.11350030783450352350Not specifiedNot specifiedNot specified
116Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.1450003078315001174500Not specifiedNot specifiedNot specified
117Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.11200030783400313200Not specifiedNot specifiedNot specified
118Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.112330303.3713.37Not specifiedNot specifiedNot specified
119Russian FederationGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab0.2422123790307.2670793513957.192015Not specifiedNot specifiedNot specified
120Republic of KazakhstanGovernmentMerck Sharp & DohmeEfavirenz50mg tab0.6669750---460352015Not specifiedNot specifiedNot specified
121Republic of ArmeniaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.10332340909.326241.8VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-11Not specifiedNot specifiedNot specified
122Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103389370909.39939234.9UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
123UkraineGlobal FundHetero labs Ltd.Efavirenz600mg tab0.102330303.0713.072015Not specifiedNot specifiedNot specified
124Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.112330303.3713.37Not specifiedNot specifiedNot specified
125Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.4353145377003013.064845906328745.52015Not specifiedNot specifiedNot specified
126Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab5.853900030175.51300228150Not specifiedNot specifiedNot specified
127Republic of KazakhstanGovernmentZhangjiagang Huachang Pharmaceutical Industry Limited Company, ChinaEfavirenz600mg tab0.085379800302.5512660322832015Not specifiedNot specifiedNot specified
128Republic of LatviaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.388303041.64141.64Not specifiedNot specifiedNot specified
129Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Efavirenz200mg tab0.09424770908.4853449.44IDA Foundation2015Not specifiedYesNot specified
130Republic of LithuaniaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab2.351303070.53170.53Not specifiedYesNot specified
131UkraineGovernmentStrides Arcolab LimitedEfavirenz200mg tab0.1172924309010.55102710834.852016Not specifiedNot specifiedNot specified
132Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab3.2467450090292.25014610Not specifiedNot specifiedNot specified
133Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.4353145377003013.064845906328745.52015Not specifiedNot specifiedNot specified
134GeorgiaGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1063867960303.192893292293.08partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
135Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz50mg caps0.4467379503013.4126516951YesYesNot specified
136Russian FederationGovernmentARS PharmEfavirenzEfavirenz200mg tab0.24972850307.4995711.552015Not specifiedNot specifiedNot specified
137Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz600mg tab0.4596264003013.7720880287517.59YesYesNot specified
138Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedEfavirenz600mg tab0.08423741100302.527913701994252.382015Not specifiedNot specifiedNot specified
139Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.116721000303.57002450VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
140Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103390909.319.3Not specifiedNot specifiedNot specified
141Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103390909.319.3Not specifiedNot specifiedNot specified
142Russian FederationGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab0.22291726209020.06191838475.082015Not specifiedNot specifiedNot specified
143Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1167-303.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
144GeorgiaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103332400909.33603348partnership for supply. chain management (PFSCM)2015Not specifiedYesNot specified
145Republic of KazakhstanGovernmentZhangjiagang Huachang Pharmaceutical Industry Limited Company, ChinaEfavirenz200mg tab0.0162624400901.442916041990.42015Not specifiedNot specifiedNot specified
146Republic of LithuaniaGovernmentGreat BritainStocrinEfavirenz600mg tab2.4883303074.65174.65Merck Sharp & Dohme LtdNot specifiedYesNot specified
147UkraineGovernmentStrides Arcolab LimitedEfavirenz600mg tab0.11072127180303.3270906235407.922016Not specifiedNot specifiedNot specified
148Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz600mg tab0.8667810603026270270252IDA Foundation2015Not specifiedYesNot specified
149Russian FederationGovernmentPharmasyntezRegastEfavirenz100mg tab0.075227370302.25757917052.752015Not specifiedNot specifiedNot specified
150Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz600mg tab0.705712765003021.1742550900783.5Фарматех ЗАО2015Not specifiedNot specifiedNot specified
151Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Efavirenz50mg caps0.1147590303.42253865.26IDA Foundation2015Not specifiedYesNot specified
152Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz200mg tab0.2588190809023.292124937.48YesYesNot specified
153Republic of EstoniaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.7573303052.72152.72Not specifiedNot specifiedNot specified
154Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabin+Tenofovir Disoproxil600mg+200mg+245mg tab26.436600030793.08200158616Not specifiedNot specifiedNot specified
155Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabin+Tenofovir Disoproxil600mg+200mg+245mg tab26.436900030793.08300237924Not specifiedNot specifiedNot specified
156Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.41531904703012.46634979108.54IDA Foundation2015Not specifiedYesNot specified
157Republiс of AzerbaijanGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1.3264089603039.7813632542280.94YesYesNot specified
158Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab26.4369150030793.0830502418894Not specifiedNot specifiedNot specified
159Kyrgyz RepublicGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.3752322903011.25774387108.75UNDP/UNICEF2015Not specifiedNot specifiedNot specified
160Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab2.8033990003084.13300277530Фарматех ЗАО2015Not specifiedNot specifiedNot specified
161Republic of TajikistanGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.375303011.25111.25Not specifiedNot specifiedNot specified
162UkraineGlobal FundMerck Sharp & DohmeEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab13030301302015Not specifiedNot specifiedNot specified
163UkraineGovernmentMerck Sharp & DohmeEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1.16373504603034.9111682407818.622016Not specifiedNot specifiedNot specified
164Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.324721960309.747327129.68VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
165Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.1667750003087525002187500Not specifiedNot specifiedNot specified
166Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.166733000308751100962500Not specifiedNot specifiedNot specified
167Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.1667510003087517001487500Not specifiedNot specifiedNot specified
168Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps8.3293180030249.886014992.8Not specifiedNot specifiedNot specified
169Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps8.3293210030249.887017491.6Not specifiedNot specifiedNot specified
170Russian FederationGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+300mg+25mg tab29.51032094030885.31698617946.382015Not specifiedNot specifiedNot specified
171Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.773320100030803.267005381440Not specifiedNot specifiedNot specified
172Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.77333000030803.21000803200Not specifiedNot specifiedNot specified
173Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.77337350030803.224501967840Not specifiedNot specifiedNot specified
174Kyrgyz RepublicGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.2003-306.01--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
175Republic of LatviaGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab15.64273030469.281469.28Not specifiedNot specifiedNot specified
176Republic of PolandGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab17.269318150030518.0860503134384Not specifiedNot specifiedNot specified
177Republic of BelarusGovernmentHetero Labs + ФарматехEmtricitabine+Tenofovir - FDC200mg+300mg tab2.34933176103070.4810587746171.75Фарматех ЗАО2015Not specifiedNot specifiedNot specified
178Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.17920220305.376743619.38VPP, through Partnership for Supply Chain Management (PFSCM)20152016-03-112015-10-14Not specifiedNot specifiedNot specified
179UkraineGlobal FundMacleods Pharmaceuticals LtdEmtricitabine+Tenofovir - FDC200mg+300mg tab0.178730305.3615.362015Not specifiedNot specifiedNot specified
180Russian FederationGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+300mg tab6.97339897030209.23299690150.812015Not specifiedNot specifiedNot specified
181GeorgiaGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.1973824040305.9227468162610.56partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
182Republic of MoldovaGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.222395880306.67319621317.32IDA Foundation2015Not specifiedYesNot specified
183Republic of KazakhstanGovernmentGilead SciencesEmtricitabine+Tenofovir - FDC200mg+300mg tab0.11877237800303.56241260858885.622015Not specifiedNot specifiedNot specified
184Republic of TajikistanGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.200330306.0116.01Not specifiedNot specifiedNot specified
185Republic of PolandGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml27.7512006016652033300Not specifiedNot specifiedNot specified
186Republic of LatviaGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml24.557760601473.4611473.46Not specifiedNot specifiedNot specified
187Russian FederationGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml18.170326940601090.22449489508.782015Not specifiedNot specifiedNot specified
188GeorgiaGlobal FundJanssenEtravirine100mg tab4.791757601205754827600partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
189Russian FederationGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab5.4245279966060325.4746661151867562015Not specifiedNot specifiedNot specified
190Republic of LatviaGovernmentJohnson & JohnsonIntelenceEtravirine100mg tab3.5232120120422.791422.79Not specifiedNot specifiedNot specified
191Republic of PolandGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab6.69151800060401.49300120447Not specifiedNot specifiedNot specified
192Republic of PolandGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab6.69154050060401.49675271005.75Not specifiedNot specifiedNot specified
193UkraineGovernmentJanssenEtravirine100mg tab2.892223880120347.0619969064.942016Not specifiedNot specifiedNot specified
194Russian FederationGovernmentJohnson & JohnsonIntelenceEtravirine100mg tab2.7487454440120329.85378712491422015Not specifiedNot specifiedNot specified
195Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir700mg tab3.3357214368060200.143572871506022015Not specifiedNot specifiedNot specified
196Republic of LatviaGovernmentViiV HealthcareTelzirFosamprenavir700mg tab4.87336060292.41292.4Not specifiedNot specifiedNot specified
197Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir50mg/ml oral solution 225ml60.212608160.212608157027.692015Not specifiedNot specifiedNot specified
198Republic of KazakhstanGovernmentViiV HealthcareLamivudine100mg tab0.0251747200601.529120436802015Not specifiedNot specifiedNot specified
199Republic of TajikistanGlobal FundViiV HealthcareLamivudine150mg tab0.038360602.312.3Not specifiedNot specifiedNot specified
200Republic of PolandGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml47.5450147.545021375Not specifiedNot specifiedNot specified
201Russian FederationGovernmentHetero labs Ltd.Heptavir 150Lamivudine150mg tab0.06471604940603.8826749103786.122015Not specifiedNot specifiedNot specified
202UkraineGovernmentAurobindo Pharma Ltd.Lamivudine150mg tab0.04032190960602.423651688368.722016Not specifiedNot specifiedNot specified
203Republic of UzbekistanGlobal FundCipla LtdLamivudine10mg/ml oral solution 100ml2.2-12.2--Not specifiedNot specifiedNot specified
204Russian FederationGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml30.5744581130.57445811362841.122015Not specifiedNot specifiedNot specified
205Republic of LatviaGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml38.04-138.04--Not specifiedNot specifiedNot specified
206Republic of LithuaniaGovernmentMerck Sharp & DohmeZeffixLamivudine100mg tab2.6661282874.65174.65Not specifiedNot specifiedNot specified
207Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lamivudine10mg/ml oral solution 240ml2.35-12.35--Not specifiedNot specifiedNot specified
208Kyrgyz RepublicGlobal FundHetero labs Ltd.Lamivudine150mg tab0.0383-602.3--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
209Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Lamivudine100mg tab0.05973300603.5855196.9IDA Foundation2015Not specifiedYesNot specified
210Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedLamivudine150mg tab0.0312740400601.82123403822122015Not specifiedNot specifiedNot specified
211Russian FederationGovernmentPharmasyntezAmivirenLamivudine150mg tab0.055322779840603.323796641260484.52015Not specifiedNot specifiedNot specified
212Republic of KazakhstanGovernmentViiV HealthcareLamivudine150mg tab0.0313288000601.88480090242015Not specifiedNot specifiedNot specified
213Republic of TajikistanGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 100ml1.2-11.2--Not specifiedNot specifiedNot specified
214Russian FederationGovernmentAurobindo Pharma Ltd.LamivudineLamivudine150mg tab0.16337787220609.81297871271912.622015Not specifiedNot specifiedNot specified
215Republic of EstoniaGovernmentViiV HealthcareEpivirLamivudine150mg tab3.39026060203.411203.41Not specifiedNot specifiedNot specified
216Republic of BelarusGovernmentHetero Labs + ФарматехLamivudine150mg tab0.52378365806031.4213943438089.06Фарматех ЗАО2015Not specifiedNot specifiedNot specified
217UkraineGovernmentCipla LtdLamivudine10mg/ml oral solution 100ml0.0179259610.017925967925.962016Not specifiedNot specifiedNot specified
218Russian FederationGovernmentViiV HealthcareEpivirLamivudine150mg tab0.34351374006020.61229047196.92015Not specifiedNot specifiedNot specified
219Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Lamivudine10mg/ml oral solution 240ml4.7637914.763791804.04IDA Foundation2015Not specifiedYesNot specified
220Republic of UzbekistanGlobal FundHetero labs Ltd.Lamivudine150mg tab0.03960602.3412.34Not specifiedNot specifiedNot specified
221Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Lamivudine10mg/ml oral solution 240ml8.1453318.145334338.62YesYesNot specified
222GeorgiaGlobal FundAurobindo Pharma Ltd.Lamivudine150mg tab0.035832400602.155401161partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
223Republic of ArmeniaGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 240ml1.533911.533959.67VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
224Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDLamivudine150mg tab0.033321006023570VPP, through Partnership for Supply Chain Management (PFSCM)20152016-03-112015-10-14Not specifiedNot specifiedNot specified
225Kyrgyz RepublicGlobal FundHetero labs Ltd.Lamivudine100mg tab0.0383-602.3--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
226UkraineGlobal FundSun Pharmaceutical Industries LimitedLamivudine150mg tab0.033760602.0212.022015Not specifiedNot specifiedNot specified
227Republic of KazakhstanGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml24.663740124.66374092228.42015Not specifiedNot specifiedNot specified
228Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Lamivudine150mg tab0.1945343206011.675726675.24YesYesNot specified
229Republic of LatviaGovernmentViiV HealthcareEpivirLamivudine300mg tab5.24273030157.281157.28Not specifiedNot specifiedNot specified
230Russian FederationGovernmentPharmasyntezAmivirenLamivudine300mg tab0.30774079520309.231359841255132.382015Not specifiedNot specifiedNot specified
231GeorgiaGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 240ml1.9540011.95400780partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
232Republic of PolandGovernmentLimited t/a MylanLamivudineLamivudine150mg tab0.88131380006052.882300121624Not specifiedNot specifiedNot specified
233Republic of KazakhstanGovernmentJSC Nobel Almaty Pharmaceutical FactoryLamivudine100mg tab0.023239400601.3839905506.22015Not specifiedNot specifiedNot specified
234Russian FederationGovernmentVialLamivudine-VialLamivudine150mg tab0.38474192206023.086987161259.952015Not specifiedNot specifiedNot specified
235Republic of ArmeniaGlobal FundCipla LtdLamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.13915840608.342642201.76VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
236Republic of TajikistanGlobal FundMatrixLamivudine+Nevirapine+Zidovudine - FDC30mg+50mg+60mg tab0.060860603.6513.65Not specifiedNot specifiedNot specified
237Republic of MoldovaGlobal FundRanbaxy Laboratories LimitedLamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.1652131400609.91219021702.92015Not specifiedYesNot specified
238Russian FederationGovernmentHetero labs Ltd.Zidolam-NLamivudine+Nevirapine+Zidovudine - FDC300mg+200mg+150mg tab0.95421410606057.252351134594.752015Not specifiedNot specifiedNot specified
239Republic of TajikistanGlobal FundCipla LtdLamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.156760609.419.4Not specifiedNot specifiedNot specified
240UkraineGovernmentHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.40735063703012.2216879206261.382016Not specifiedNot specifiedNot specified
241Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDLamivudine+Tenofovir - FDC300mg tab0.173330305.215.2Not specifiedNot specifiedNot specified
242Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.192767710305.78225713045.46IDA Foundation2015Not specifiedNoNot specified
243Russian FederationGovernmentHetero labs Ltd.ZidolamLamivudine+Zidovudine 150mg+300mg tab0.3568119438406021.4119906442619602015Not specifiedNot specifiedNot specified
244Republic of BelarusGovernmentHetero Labs + ФарматехLamivudine+Zidovudine 150mg+300mg tab0.24325686606014.5842811624184.38Фарматех ЗАО2015Not specifiedNot specifiedNot specified
245Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDLamivudine+Zidovudine 150mg+300mg tab0.118360607.117.1Not specifiedNot specifiedNot specified
246Republic of LithuaniaGovernmentЛех АноCombivirLamivudine+Zidovudine 150mg+300mg tab2.57176060154.31154.3Not specifiedNot specifiedNot specified
247Republic of MoldovaGlobal FundRanbaxy Laboratories LimitedLamivudine+Zidovudine 150mg+300mg tab0.1295149040607.77248419300.68IDA Foundation2015Not specifiedYesNot specified
248Russian FederationGovernmentRanbaxy Laboratories LimitedVirocombLamivudine+Zidovudine 150mg+300mg tab0.528563583806031.711059733360403.752015Not specifiedNot specifiedNot specified
249Republic of LatviaGovernmentTeva BVLamivudine / Zidovudine TevaLamivudine+Zidovudine 150mg+300mg tab0.9232606055.39155.39Not specifiedNot specifiedNot specified
250Republic of KazakhstanGovernmentMYLAN LABORATORIES LTDLamivudine+Zidovudine 150mg+300mg tab0.03327846000601.984641009189182015Not specifiedNot specifiedNot specified
251Republic of LithuaniaGovernmentTeva BVLamivudine+Zidovudine 150mg+300mg tab2.57176060154.31154.3Not specifiedNot specifiedNot specified
252Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDLamivudine+Zidovudine 150mg+300mg tab0.1149380606.68235431.8VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
253Republic of TajikistanGlobal FundViiV HealthcareLamivudine+Zidovudine 150mg+300mg tab0.118360607.117.1Not specifiedNot specifiedNot specified
254Republic of PolandGovernmentCipla LtdLAZIVIRLamivudine+Zidovudine 150mg+300mg tab0.27051200006016.23200032460Not specifiedNot specifiedNot specified
255Republic of EstoniaGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab4.91876060295.121295.12Not specifiedNot specifiedNot specified
256UkraineGovernmentAurobindo Pharma Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.10575853900606.3497565618562.122016Not specifiedNot specifiedNot specified
257Republic of LatviaGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab0.9232606055.39155.39Not specifiedNot specifiedNot specified
258Republic of TajikistanGlobal FundMatrixLamivudine+Zidovudine 30mg+60mg tab0.031760601.911.9Not specifiedNot specifiedNot specified
259Russian FederationGovernmentPharmasyntezDizaveroxLamivudine+Zidovudine 150mg+300mg tab0.3738171549006022.432859156413073.52015Not specifiedNot specifiedNot specified
260Kyrgyz RepublicGlobal FundHetero labs Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.1152-606.91--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
261Republic of LithuaniaGovernmentViiv Healthcare UK LimitedCombivirLamivudine+Zidovudine 150mg+300mg tab2.57176060154.31154.3Not specifiedNot specifiedNot specified
262Russian FederationGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab0.59451580406035.67263493954.782015Not specifiedNot specifiedNot specified
263UkraineGovernmentMatrixLamivudine+Zidovudine 30mg+60mg tab0.041754600602.591022752016Not specifiedNot specifiedNot specified
264Republic of KazakhstanGovernmentViiV HealthcareLamivudine+Zidovudine 150mg+300mg tab0.051298622000603.07164370050461592015Not specifiedNot specifiedNot specified
265GeorgiaGlobal FundRanbaxy Laboratories LimitedLamivudine+Zidovudine 150mg+300mg tab0.1058681120606.351135272085.2partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
266UkraineGlobal FundHetero labs Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.104260606.2516.252015Not specifiedNot specifiedNot specified
267Republiс of AzerbaijanGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab0.41884374006025.137290183197.7YesYesNot specified
268Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.42921500060205.7525051437.5Not specifiedNot specifiedNot specified
269Republic of MoldovaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.4321850512.163704499.2IDA Foundation2015Not specifiedYesNot specified
270Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.69686060101.811101.81Not specifiedYesNot specified
271UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.54181303212012065.0210860170612372016Not specifiedNot specifiedNot specified
272Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.4291240000120411.492000822980Not specifiedNot specifiedNot specified
273Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506784816012060.87068429734.41UNICEF Supply Division20152015-11-252016-03-01Not specifiedNot specifiedNot specified
274GeorgiaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16255560.8513100.8partnership for supply. chain management (PFSCM)2015NoYesNot specified
275Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.4264180000120411.171500616755Not specifiedNot specifiedNot specified
276Republic of KazakhstanGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.007885190400600.471419840667324.812015Not specifiedNot specifiedNot specified
277Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml74.576-5372.88--2015Not specifiedYesNot specified
278GeorgiaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506745144012060.83762228729.59partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
279Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.6984120120443.811443.81Not specifiedNot specifiedNot specified
280Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.7982505308.995015449.5Not specifiedNot specifiedNot specified
281Republic of KazakhstanGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.00224428000600.137380095942015Not specifiedNot specifiedNot specified
282Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml81.46855407.341407.34Not specifiedNot specifiedNot specified
283Russian FederationGovernmentAbbottKaletraLopinavir+Ritonavir - FDC200mg+50mg tab1.050882860720120126.1690506870728082015Not specifiedNot specifiedNot specified
284Republic of ArmeniaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.50678460012060.870542864VPP, through Partnership for Supply Chain Management (PFSCM)20152015-05-112015-10-14Not specifiedNot specifiedNot specified
285Republic of UzbekistanGlobal FundAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--Not specifiedNot specifiedNot specified
286Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.42921260000120411.5105004320750Not specifiedNot specifiedNot specified
287Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.506712012060.8160.8Not specifiedNot specifiedNot specified
288UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.270813014606016.2521691352478.752016Not specifiedNot specifiedNot specified
289Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.71376060102.821102.82Not specifiedNot specifiedNot specified
290Kyrgyz RepublicGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg/ml+20mg/ml oral solution 100ml12.16-560.8--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
291Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506718000012060.8150091200UNICEF Supply Division20152015-11-192016-02-17Not specifiedNot specifiedNot specified
292UkraineGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506712012060.8160.82015Not specifiedNot specifiedNot specified
293Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506796876012060.88073490838.41IDA Foundation2015Not specifiedYesNot specified
294Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.3937120120407.251407.25Not specifiedYesNot specified
295Republiс of AzerbaijanGovernmentAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab1.2519495360120150.234128620149.44YesYesNot specified
296Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.4292480060205.758016460Not specifiedNot specifiedNot specified
297Republiс of AzerbaijanGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml42.09821005210.4942088405.8YesYesNot specified
298Republic of TajikistanGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.128360607.717.7Not specifiedNot specifiedNot specified
299Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml88.762-5443.81--Not specifiedNot specifiedNot specified
300Republic of KazakhstanGovernmentAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.37211175511.86223526507.12015Not specifiedNot specifiedNot specified
301Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab2.9628120120355.541355.54Not specifiedNot specifiedNot specified
302Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.02811201203.3713.37Not specifiedNot specifiedNot specified
303Russian FederationGovernmentAbbottKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.724894344060103.49157241627276.752015Not specifiedNot specifiedNot specified
304Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.50674980012060.841525232UNICEF Supply Division20152015-12-222016-03-01Not specifiedNot specifiedNot specified
305Republic of TajikistanGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--Not specifiedNot specifiedNot specified
306Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.837553097523175Not specifiedNot specifiedNot specified
307UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml0.236100717051.18201434237692.122016Not specifiedNot specifiedNot specified
308Kyrgyz RepublicGlobal FundCipla LtdLopinavir+Ritonavir - FDC200mg+50mg tab0.2083-12025--UNDP/UNICEF2015Not specifiedNot specifiedNot specified
309Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506712000012060.8100060800UNICEF Supply Division20152015-11-042016-01-30Not specifiedNot specifiedNot specified
310Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc150mg tab14.16672400608504034000Not specifiedNot specifiedNot specified
311Russian FederationGovernmentViiV HealthcareCelsentriMaraviroc300mg tab6.86221560060411.73260107049.82015Not specifiedNot specifiedNot specified
312Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc300mg tab14.16671440060850240204000Not specifiedNot specifiedNot specified
313Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc300mg tab14.16674800608508068000Not specifiedNot specifiedNot specified
314Republic of LatviaGovernmentViiV HealthcareCelsentriMaraviroc300mg tab12.85236060771.141771.14Not specifiedNot specifiedNot specified
315Russian FederationGovernmentViiV HealthcareCelsentriMaraviroc150mg tab3.8402312060230.415211981.322015Not specifiedNot specifiedNot specified
316Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc150mg tab14.1667720060850120102000Not specifiedNot specifiedNot specified
317Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc300mg tab14.166760006085010085000Not specifiedNot specifiedNot specified
318UkraineGlobal FundHetero labs Ltd.Nevirapine (NVP)200mg tab0.041260602.4712.472015Not specifiedNot specifiedNot specified
319Republic of KazakhstanGovernmentBoehringer IngelheimViramuneNevirapine (NVP)10mg/ml oral solution 240ml19.764010119.76401079237.62015Not specifiedNot specifiedNot specified
320Russian FederationGovernmentDrugs technologyNevirapine-TLNevirapine (NVP)200mg tab0.12421016820607.4516947126255.152015Not specifiedNot specifiedNot specified
321Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)50mg tab0.04172430301.2581101.25UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
322Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)10mg/ml oral solution 100ml1.25-11.25--Not specifiedNot specifiedNot specified
323Republiс of AzerbaijanGovernmentCipla LtdNevirapine (NVP)10mg/ml oral solution 240ml108011080800YesYesNot specified
324Republic of TajikistanGlobal FundBoehringer IngelheimNevirapine (NVP)10mg/ml oral solution 240ml1.35-11.35--Not specifiedNot specifiedNot specified
325Republiс of AzerbaijanGovernmentHetero labs Ltd.Nevirapine (NVP)200mg tab0.19151140606011.49190121842.49YesYesNot specified
326Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)200mg tab0.0460602.412.4Not specifiedNot specifiedNot specified
327Republic of MoldovaGlobal FundHetero labs Ltd.Nevirapine (NVP)200mg tab0.053525860603.214311383.51IDA Foundation2015Not specifiedYesNot specified
328UkraineGovernmentStrides Arcolab LimitedNevirapine (NVP)200mg tab0.0417423360602.57056176402016Not specifiedNot specifiedNot specified
329Kyrgyz RepublicGlobal FundStrides Arcolab LimitedNevirapine (NVP)200mg tab0.0375-602.25--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
330Republic of KazakhstanGovernmentBoehringer IngelheimNevirapine (NVP)200mg tab0.01031479600600.622466015289.22015Not specifiedNot specifiedNot specified
331Republic of ArmeniaGlobal FundCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml1.258411.2584105VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
332Russian FederationGovernmentBoehringer IngelheimViramuneNevirapine (NVP)10mg/ml oral solution 240ml12.7512170112.7512170155167.52015Not specifiedNot specifiedNot specified
333Kyrgyz RepublicGlobal FundCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml2.335512.3355128.15UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
334Republic of BelarusGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)10mg/ml oral solution 100ml1.543211.5432648IDA Foundation20152015-12-222016-05-28Not specifiedNot specifiedNot specified
335Republic of KazakhstanGovernmentEmcure Pharmaceuticals Ltd.Nevirapine (NVP)200mg tab0.010345568800600.62759480470877.592015Not specifiedNot specifiedNot specified
336Russian FederationGovernmentPharmasyntezNevirpineNevirapine (NVP)200mg tab0.319827007206019.1945012863780.252015Not specifiedNot specifiedNot specified
337Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDNevirapine (NVP)200mg tab0.036711460602.2191420.2VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
338Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)200mg tab0.040860602.4512.45Not specifiedNot specifiedNot specified
339Republic of UzbekistanGlobal FundCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml1.25-11.25--Not specifiedNot specifiedNot specified
340Republic of PolandGovernmentCipla LtdViramuneNevirapine (NVP)400mg tab1.7917750003053.752500134375Not specifiedNot specifiedNot specified
341UkraineGovernmentCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml0.0119000010.0119000019002016Not specifiedNot specifiedNot specified
342Republic of LatviaGovernmentBoehringer IngelheimViramuneNevirapine (NVP)200mg tab3.08026060184.811184.81Not specifiedNot specifiedNot specified
343Russian FederationGovernmentAZT PHARMA K.B.NikavirPhosphazide200mg tab0.64120723802012.821036191328395.622015Not specifiedNot specifiedNot specified
344Russian FederationGovernmentAZT PHARMA K.B.NikavirPhosphazide400mg tab0.633527445806038.01457431738691.382015Not specifiedNot specifiedNot specified
345Republic of LatviaGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab11.03586060662.151662.15Not specifiedNot specifiedNot specified
346Republic of LatviaGovernmentMerck Sharp & DohmeIsentressRaltegravir25mg tab0.7737606046.42146.42Not specifiedNot specifiedNot specified
347UkraineGovernmentMerck Sharp & DohmeRaltegravir400mg tab6.78833534060407.3589239899.72016Not specifiedNot specifiedNot specified
348Republic of BelarusGlobal FundMerck Sharp & DohmeRaltegravir400mg tab13.16673120607905241080IDA Foundation20152015-01-132015-05-22Not specifiedNot specifiedNot specified
349Republic of PolandGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab7.86627800060471.971300613561Not specifiedNot specifiedNot specified
350Republic of PolandGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab7.86623000060471.97500235985Not specifiedNot specifiedNot specified
351Republic of LatviaGovernmentMerck Sharp & DohmeIsentressRaltegravir100mg tab3.06536060183.921183.92Not specifiedNot specifiedNot specified
352Republic of ArmeniaGlobal FundMerck Sharp & DohmeRaltegravir400mg tab18.118060108633258VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
353GeorgiaGlobal FundSchering Plough Central East AGRaltegravir400mg tab14.118720060847.08120101649.6partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
354Republic of BelarusGlobal FundMerck Sharp & DohmeRaltegravir400mg tab13.16673600607906047400IDA Foundation20152015-01-132015-04-18Not specifiedNot specifiedNot specified
355Republic of PolandGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab7.866228800060471.9748002265456Not specifiedNot specifiedNot specified
356Russian FederationGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab9.2565380958060555.3963493352633762015Not specifiedNot specifiedNot specified
357Republic of LithuaniaGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab12.00556060720.331720.33Not specifiedNot specifiedNot specified
358Republic of PolandGovernmentJohnson & JohnsonEdurantRilpivirine25mg tab9.16671800302756016500Not specifiedNot specifiedNot specified
359Republic of PolandGovernmentJohnson & JohnsonEdurantRilpivirine25mg tab9.16671890030275630173250Not specifiedNot specifiedNot specified
360Russian FederationGovernmentJohnson & JohnsonEdurantRilpivirine25mg tab17.33733216030520.121072557568.622015Not specifiedNot specifiedNot specified
361Republic of PolandGovernmentAbbVieNorvirRitonavir (RTV)100mg tab0.0903360000302.711200032520Not specifiedNot specifiedNot specified
362Republiс of AzerbaijanGovernmentHetero labs Ltd.Ritonavir (RTV)100mg tab2.016757603060.519211616YesYesNot specified
363GeorgiaGlobal FundAbbVieRitonavir (RTV)100mg tab1.096622803032.88207668258.88partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
364Russian FederationGovernmentHetero labs Ltd.Ritonavir-100Ritonavir (RTV)100mg caps0.9443109175406056.66181959103097972015Not specifiedNot specifiedNot specified
365Republic of BelarusGlobal FundAbbVieRitonavir (RTV)100mg tab0.855216003025.6572018468UNICEF Supply Division20152015-12-222016-05-21Not specifiedNot specifiedNot specified
366Republic of PolandGovernmentAbbVieNorvirRitonavir (RTV)100mg tab1.45834500003043.7515000656250Not specifiedNot specifiedNot specified
367Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDRitonavir (RTV)100mg tab0.30315990309.095334844.97IDA Foundation2015Not specifiedYesNot specified
368Republic of LithuaniaGovernmentAbbVieNorvirRitonavir (RTV)100mg tab1.0767303032.3132.3Not specifiedNot specifiedNot specified
369Republic of LatviaGovernmentAbbVieNorvirRitonavir (RTV)100mg tab0.748303022.44122.44Not specifiedNot specifiedNot specified
370UkraineGovernmentAbbVieRitonavir (RTV)100mg tab0.914484803027.42161644310.722016Not specifiedNot specifiedNot specified
371Russian FederationGovernmentIrwin 2RinvirRitonavir (RTV)100mg caps1.1163199803033.4966622304.342015Not specifiedNot specifiedNot specified
372Russian FederationGovernmentAbbottNorvirRitonavir (RTV)100mg caps1.062954081009095.66600905748209.52015Not specifiedNot specifiedNot specified
373Republic of ArmeniaGlobal FundAbbVieRitonavir (RTV)100mg tab1.0966003032.8820657.6VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
374Russian FederationGovernmentRocheInviraseSaquinavir500mg tab1.5746414600120188.953455652822.252015Not specifiedNot specifiedNot specified
375Republic of PolandGovernmentRocheInviraseSaquinavir500mg tab2.5825192000120309.91600495840Not specifiedNot specifiedNot specified
376Russian FederationGovernmentPharmasyntezInterfastSaquinavir500mg tab1.63172237160120195.8186433650299.52015Not specifiedNot specifiedNot specified
377Republic of PolandGovernmentRocheInviraseSaquinavir500mg tab2.582518000120309.915046485Not specifiedNot specifiedNot specified
378Republic of LatviaGovernmentRocheInviraseSaquinavir500mg tab2.4327120120291.931291.93Not specifiedNot specifiedNot specified
379Republic of PolandGovernmentRocheInviraseSaquinavir500mg tab2.582554000120309.9450139455Not specifiedNot specifiedNot specified
380Russian FederationGovernmentHetero labs Ltd.StagStavudine (d4T)30mg caps0.577112031045632.3221484694362.882015Not specifiedNot specifiedNot specified
381Russian FederationGovernmentVeropharmVero-StavudineStavudine (d4T)30mg caps0.60057834965633.6313991470517.342015Not specifiedNot specifiedNot specified
382Russian FederationGovernmentBristol-Myers SquibbZeritStavudine (d4T)1mg/ml powder 260ml11.94544111.9454454073.62015Not specifiedNot specifiedNot specified
383Russian FederationGovernmentVeropharmVero-StavudineStavudine (d4T)30mg caps0.60057834965633.6313991470517.342015Not specifiedNot specifiedNot specified
384Republic of KazakhstanGovernmentHetero labs Ltd.Stavudine (d4T)30mg caps0.00271165920560.152082031232015Not specifiedNot specifiedNot specified
385UkraineGovernmentHetero labs Ltd.Tenofovir (TDF)300mg tab0.1147645870303.442152974059.762016Not specifiedNot specifiedNot specified
386Republiс of AzerbaijanGovernmentHetero labs Ltd.Tenofovir (TDF)300mg tab0.5547111603016.643726190.08YesYesNot specified
387Republic of LatviaGovernmentGilead SciencesTenofovir (TDF)300mg tab8.9513030268.531268.53Not specifiedNot specifiedNot specified
388Republic of KazakhstanGovernmentGilead SciencesTenofovir (TDF)300mg tab0.08472049300302.5468310173507.412015Not specifiedNot specifiedNot specified
389Republic of LithuaniaGovernmentGilead SciencesTenofovir (TDF)300mg tab15.1553030454.651454.65GileadNot specifiedYesNot specified
390UkraineGlobal FundMacleods Pharmaceuticals LtdTenofovir (TDF)300mg tab0.106330303.1913.192015Not specifiedNot specifiedNot specified
391Republic of MoldovaGlobal FundHetero labs Ltd.Tenofovir (TDF)300mg tab0.1763750305.28125660IDA Foundation2015Not specifiedYesNot specified
392Kyrgyz RepublicGlobal FundHetero labs Ltd.Tenofovir (TDF)300mg tab0.1251080303.7536135UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
393Republic of BelarusGovernmentHetero Labs + ФарматехTenofovir (TDF)300mg tab1.781650003053.45500293700Фарматех ЗАО2015Not specifiedNot specifiedNot specified
394Russian FederationGovernmentDrugs technologyTenofovirTenofovir (TDF)300mg tab3.862734515030115.88115051333199.382015Not specifiedNot specifiedNot specified
395Republic of PolandGovernmentTeva BVTenofovir disoproxilTenofovir disoproxil245mg tab5.78710500030173.613500607635Not specifiedNot specifiedNot specified
396Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDTenofovir+Lamivudine+Efavirenz300mg+300mg+600mg tab0.274730308.2418.24Not specifiedNot specifiedNot specified
397Republic of MoldovaGlobal FundHetero labs Ltd.Tenofovir+Lamivudine+Efavirenz300mg+300mg+600mg tab0.3861886703011.58628972826.62IDA Foundation2015Not specifiedNoNot specified
398Republic of PolandGovernmentGilead SciencesTruvadaTenofovir/Emtricitabinum300mg+200mg tab17.269387000030518.082900015024320Not specifiedNot specifiedNot specified
399Republic of PolandGovernmentGilead SciencesTruvadaTenofovir/Emtricitabinum245mg+200mg tab17.26933600030518.081200621696Not specifiedNot specifiedNot specified
400UkraineGovernmentHetero labs Ltd.Tenofovir/Emtricitabinum300mg+200mg tab0.1981615110305.9453837319791.782016Not specifiedNot specifiedNot specified
401Republiс of AzerbaijanGovernmentGilead SciencesTruvadaTenofovir/Emtricitabinum300mg+200mg tab0.8075824803024.2119416470061.38YesYesNot specified
402Republic of LithuaniaGovernmentGilead SciencesTruvadaTenofovir/Emtricitabinum300mg+200mg tab22.9913030689.731689.73Not specifiedYesNot specified
403Russian FederationGovernmentBoehringer IngelheimAptivusTipranavir250mg caps6.330836000120759.73002279102015Not specifiedNot specifiedNot specified
404Republic of LatviaGovernmentBoehringer IngelheimAptivusTipranavir250mg caps6.1753120120741.031741.03Not specifiedNot specifiedNot specified
405Russian FederationGovernmentAurobindo Pharma Ltd.ZidovudineZidovudine (AZT or ZDV)300mg tab0.22860552606013.681009211380599.252015Not specifiedNot specifiedNot specified
406GeorgiaGlobal FundHetero labs Ltd.Zidovudine (AZT or ZDV)10mg/ml oral solution 240ml218412184368partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
407Republic of EstoniaGovernmentViiV HealthcareRetrovirZidovudine (AZT or ZDV)10mg/ml oral solution 200ml86.63-186.63--Not specifiedNot specifiedNot specified
408Republic of BelarusGovernmentPharmasyntez